Five pharmaceutical companies have announced they have filed a complaint in a Canadian court challenging the constitutionality of new regulations in the country. The rulings were part of an effort to lower patented drug prices.
Five pharmaceutical companies have announced they have filed a complaint in a Canadian court challenging the constitutionality of new regulations in the country. The rulings were part of an effort to lower patented drug prices.